Jay Shepard - 13 May 2021 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: Director
Signature: /s/ Jay P. Shepard
Issuer symbol: INO
Transactions as of: 13 May 2021
Net transactions value: $0
Form type: 4
Filing time: 17 May 2021, 16:28:15 UTC
Next filing: 28 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INO	Common Stock	Options Exercise		+8,700	+204%		12,974	14 May 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Common Stock Options	Award	$0	+27,000		$0.000000	27,000	13 May 2021	Common Stock	27,000	$6.23	Direct	F2, F3
transaction	INO	Restricted Stock Unit	Award	$0	+18,000		$0.000000	18,000	13 May 2021	Common Stock	18,000		Direct	F2, F4
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-8,700	-100%	$0.000000^*	0	14 May 2021	Common Stock	8,700		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 14, 2021.
F2	This grant was made pursuant to the issuer's non-employee director compensation policy.
F3	Options to vest 100% on May 13, 2022.
F4	Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 13, 2022.